Pulmonary Complications of Polymyositis and Dermatomyositis

Handbook of Systemic Autoimmune Diseases

Volumn 2, Issue , 2004, Pages 209-226

  Deng, Jane ^a   Keane, Michael P ^b   Lynch III, Joseph P ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63849219107     PISSN: 15715078     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1571-5078(04)02011-2     Document Type: Review

References (138)

1. Adams-Gandhi L.B., Boyd A.S., and King Jr. L.E. Diagnosis and management of dermatomyositis. Compr. Ther. 22 (1996) 156-164
2. Akira M., Hara H., and Sakatani M. Interstitial lung disease in association with polymyositis-dermatomyositis: long-term follow-up CT evaluation in seven patients. Radiology 210 (1999) 333-338
3. al-Janadi M., Smith C.D., and Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J. Rheumatol. 16 (1989) 1592-1596
4. American Thoracic Society (ATS). American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am. J. Respir. Crit. Care Med. 161 (2000) 646-664
5. American Thoracic Society (ATS). American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am. J. Respir. Crit. Care Med. 165 (2002) 277-304
6. Arakawa H., Yamada H., Kurihara Y., Nakajima Y., Takeda A., Fukushima Y., and Fujioka M. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest 123 (2003) 1096-1103
7. Arnett F.C., Hirsch T.J., Bias W.B., Nishikai M., and Reichlin M. The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J. Rheumatol. 8 (1981) 925-930
8. Arsura E.L., and Greenberg A.S. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin. Arthritis Rheum. 18 (1988) 29-37
9. Astudillo L.M., Carreiro M., Sailler L., Dingremont C.F., and Arlet P.M. Hypercapnic coma due to diaphragmatic involvement in a patient with dermatomyositis. Clin. Exp. Rheumatol. 19 (2001) 456-458
10. Bandoh S., Fujita J., Ohtsuki Y., Ueda Y., Hojo S., Tokuda M., Dobashi H., Kurata N., Yoshinouchi T., Kohno N., and Takahara J. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann. Rheum. Dis. 59 (2000) 257-262
11. Baumann M.H. The lung in polymyositis and dermatomyositis. Semin. Respir. Crit. Care Med. 20 (1999) 131-138
12. Benbassat J., Gefel D., Larholt K., Sukenik S., Morgenstern V., and Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum. 28 (1985) 249-255
13. Bernstein R.M., Morgan S.H., Chapman J., Bunn C.C., Mathews M.B., Turner-Warwick M., and Hughes G.R. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br. Med. J. (Clin. Res. Ed.) 289 (1984) 151-152
14. Blumbergs P.C., Byrne E., and Kakulas B.A. Polymyositis presenting with respiratory failure. J. Neurol. Sci. 65 (1984) 221-229
15. Bohan A., and Peter J.B. Polymyositis and dermatomyositis (first of two parts). N. Engl. J. Med. 292 (1975) 344-347
16. Bohan A., Peter J.B., Bowman R.L., and Pearson C.M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 56 (1977) 255-286
17. Bouros D., Wells A.U., Nicholson A.G., Colby T.V., Polychronopoulos V., Pantelidis P., Haslam P.L., Vassilakis D.A., Black C.M., and du Bois R.M. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 165 (2002) 1581-1586
18. Braun N.M., Arora N.S., and Rochester D.F. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 38 (1983) 616-623
19. Bunch T.W., Worthington J.W., Combs J.J., Ilstrup D.M., and Engel A.G. Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann. Intern. Med. 92 (1980) 365-369
20. Caproni M., Cardinali C., Parodi A., Giomi B., Papini M., Vaccaro M., Marzano A., De Simone C., Fazio M., Rebora A., and Fabbri P. Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology. Arch. Dermatol. 138 (2002) 23-27
21. Chan W.M., Ip M., Lau C.S., Wang E., and Peh W.C. Anti-Jo-1 syndrome presenting as cryptogenic organizing pneumonia. Respir. Med. 89 (1995) 639-641
22. Chang H.K., and Lee D.H. Successful combination therapy of cyclosporine and methotrexate for refractory polymyositis with anti-jo-1 antibody: a case report. J. Korean Med. Sci. 18 (2003) 131-134
23. Clawson K., and Oddis C.V. Adult respiratory distress syndrome in polymyositis patients with the anti-Jo-1 antibody. Arthritis Rheum. 38 (1995) 1519-1523
24. Cottin V., Donsbeck A.V., Revel D., Loire R., and Cordier J.F. Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med. 158 (1998) 1286-1293
25. Cottin V., Thivolet-Bejul F., Reynaud-Gaubert M., Cadranel J., Delaval P., Ternamian P.-J., and Cordier J.-F. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis, and polymyositis. Eur. Respir. J. 22 (2003) 245-250
26. Cronin M.E., and Plotz P.H. Idiopathic inflammatory myopathies. Rheum. Dis. Clin. North Am. 16 (1990) 655-665
27. Dalakas M.C. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325 (1991) 1487-1498
28. Delbrel X., Schaeverbeke T., Lifermann F., and Dehais J. Arthropathy associated with anti-Jo-1 antibody. Joint Bone Spine 68 (2001) 166-169
29. DePalo V., and McCool F. Respiratory muscle evaluation of the patient with neuromuscular disease. Semin. Respir. Crit. Care Med. 23 (2002) 201-209
30. DeVere R., and Bradley W.G. Polymyositis: its presentation, morbidity and mortality. Brain 98 (1975) 637-666
31. Dickey B.F., and Myers A.R. Pulmonary disease in polymyositis/dermatomyositis. Semin. Arthritis Rheum. 14 (1984) 60-76
32. Douglas W.W., Tazelaar H.D., Hartman T.E., Hartman R.P., Decker P.A., Schroeder D.R., and Ryu J.H. Polymyositis-dermatomyositis-associated interstitial lung disease. Am. J. Respir. Crit. Care Med. 164 (2001) 1182-1185
33. Duncan P.E., Griffin J.P., Garcia A., and Kaplan S.B. Fibrosing alveolitis in polymyositis. A review of histologically confirmed cases. Am. J. Med. 57 (1974) 621-626
34. el-Azhary R.A., and Pakzad S.Y. Amyopathic dermatomyositis: retrospective review of 37 cases. J. Am. Acad. Dermatol. 46 (2002) 560-565
35. Ellis S.M., and Hansell D.M. Idiopathic interstitial pneumonias: imaging-pathology correlation. Eur. Radiol. 12 (2002) 610-626
36. Enomoto K., Takada T., Suzuki E., Ishida T., Moriyama H., Ooi H., Hasegawa T., Tsukada H., Nakano M., and Gejyo F. Bronchoalveolar lavage fluid cells in mixed connective tissue disease. Respirology 8 (2003) 149-156
37. Euwer R.L., and Sontheimer R.D. Dermatologic aspects of myositis. Curr. Opin. Rheumatol. 6 (1994) 583-589
38. Frazier A.R., and Miller R.D. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 65 (1974) 403-407
39. Fudman E.J., and Schnitzer T.J. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am. J. Med. 80 (1986) 329-332
40. Fujita J., Tokuda M., Bandoh S., Yang Y., Fukunaga Y., Hojo S., Ueda Y., Dobashi N., Dohmoto K., Ishida T., and Takahara J. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol. Int. 20 (2001) 81-84
41. Gilchrist J. Overview of neuromuscular disorders affected respiratory function. Semin. Respir. Crit. Care Med. 23 (2002) 191-200
42. Grathwohl K.W., Thompson J.W., Riordan K.K., Roth B.J., and Dillard T.A. Digital clubbing associated with polymyositis and interstitial lung disease. Chest 108 (1995) 1751-1752
43. Grau J.M., Miro O., Pedrol E., Casademont J., Masanes F., Herrero C., Haussman G., and Urbano-Marquez A. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. J. Rheumatol. 23 (1996) 1921-1926
44. Gruhn W.B., and Diaz-Buxo J.A. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J. Rheumatol. 14 (1987) 1045-1047
45. Hausmanowa-Petrusewicz I., Kowalska-Oledzka E., Miller F.W., Jarzabek-Chorzelska M., Targoff I.N., Blaszczyk-Kostanecka M., and Jablonska S. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. Arthritis Rheum. 40 (1997) 1257-1266
46. Hidano A., Kaneko K., Arai Y., and Kikuchi R. Survey of the prognosis for dermatomyositis, with special reference to its association with malignancy and pulmonary fibrosis. J. Dermatol. 13 (1986) 233-241
47. Hidano A., Torikai S., Uemura T., and Shimizu S. Malignancy and interstitial pneumonitis as fatal complications in dermatomyositis. J. Dermatol. 19 (1992) 153-160
48. High W.A., Cohen J.B., Murphy B.A., and Costner M.I. Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis. J. Am. Acad. Dermatol. 49 (2003) 295-298
49. Hirakata M., and Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr. Opin. Rheumatol. 12 (2000) 501-508
50. Hirakata M., Mimori T., Akizuki M., Craft J., Hardin J.A., and Homma M. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum. 35 (1992) 449-456
51. Hochberg M.C., Feldman D., Stevens M.B., Arnett F.C., and Reichlin M. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease. J. Rheumatol. 11 (1984) 663-665
52. Hochberg M.C., Feldman D., and Stevens M.B. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin. Arthritis Rheum. 15 (1986) 168-178
53. Honda Y., Kuroki Y., Matsuura E., Nagae H., Takahashi H., Akino T., and Abe S. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am. J. Respir. Crit. Care Med. 152 (1995) 1860-1866
54. Ihn H., Asano Y., Kubo M., Yamane K., Jinnin M., Yazawa N., Fujimoto M., and Tamaki K. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford) 41 (2002) 1268-1272
55. Ikezoe J., Johkoh T., Kohno N., Takeuchi N., Ichikado K., and Nakamura H. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J. Thorac. Imaging 11 (1996) 250-259
56. Itoh T., Mitsuoka S., Uji M., and Matsushita H. Successful combination chemotherapy with low-dose methotrexate and steroids for dermatomyositis complicated by interstitial pneumonitis. Nihon Kokyuki Gakkai Zasshi 37 (1999) 636-640
57. Katzenstein A.L., and Fiorelli R.F. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am. J. Surg. Pathol. 18 (1994) 136-147
58. Katzenstein A.L., and Myers J.L. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am. J. Respir. Crit. Care Med. 157 (1998) 1301-1315
59. Kim D.S., Yoo B., Lee J.S., Kim E.K., Lim C.M., Lee S.D., Koh Y., Kim W.S., Kim W.D., Colby T.V., and Kitiaichi M. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc. Diffuse Lung Dis. 19 (2002) 121-127
60. Kim E.A., Lee K.S., Johkoh T., Kim T.S., Suh G.Y., Kwon O.J., and Han J. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 22 (2002) S151-S165
61. Knoell K.A., Hook M., Grice D.P., and Hendrix Jr. J.D. Dermatomyositis associated with bronchiolitis obliterans organizing pneumonia (BOOP). J. Am. Acad. Dermatol. 40 (1999) 328-330
62. Kobayashi J., and Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 108 (1995) 311-315
63. Komocsi A., Kumanovics G., Zibotics H., and Czirjak L. Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis. Rheumatol. Int. 20 (2001) 113-118
64. Kourakata H., Takada T., Suzuki E., Enomoto K., Saito I., Taguchi Y., Tsukada H., Nakano M., and Arakawa M. Flowcytometric analysis of bronchoalveolar lavage fluid cells in polymyositis/dermatomyositis with interstitial pneumonia. Respirology 4 (1999) 223-228
65. Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch. Dermatol. 111 (1975) 241-245
66. Kubo M., Ihn H., Yamane K., Kikuchi K., Yazawa N., Soma Y., and Tamaki K. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology (Oxford) 39 (2000) 632-636
67. Kuroda T., Morikawa H., Satou T., Tanabe Y., Murakami S., Ito S., Nakan M., and Gejyo F. A case of dermatomyositis complicated with pneumomediastinum successfully treated with cyclosporin A. Clin. Rheumatol. 22 (2003) 45-48
68. Lakhanpal S., Lie J.T., Conn D.L., and Martin II W.J. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann. Rheum. Dis. 46 (1987) 23-29
69. Lee C.S., Chen T.L., Tzen C.Y., Lin F.J., Peng M.J., Wu C.L., and Chen P.J. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin. Rheumatol. 21 (2002) 391-396
70. Love L.A., Leff R.L., Fraser D.D., Targoff I.N., Dalakas M., Plotz P.H., and Miller F.W. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70 (1991) 360-374
71. Lynch III J.P., and Chavis A. Chronic interstitial pulmonary disorders. In: Victor L. (Ed). Clinical Pulmonary Medicine (1992), Little Brown, Boston, MA 193-264
72. Lynch III J.P., and Hunninghake G.W. Pulmonary complications of collagen vascular disease. Annu. Rev. Med. 43 (1992) 17-35
73. Lynch III J.P., and McCune W.J. Immunosuppressive and cytotoxic pharmacotherapy for pulmonary disorders. Am. J. Respir. Crit. Care Med. 155 (1997) 395-420
74. Lynch III J.P., Orens J., and Kazerooni E. Collagen vascular disease. In: Sperber M. (Ed). Diffuse Lung Disorders: A Comprehensive Clinical-Radiological Overview (1999), Springer, London
75. Maccioni F.J., and Colebatch H.J. Management of fibrosing alveolitis with polymyositis dermatomyositis. Aust. NZ J. Med. 20 (1990) 806-810
76. Maeda K., Kimura R., Komuta K., and Igarashi T. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?. Scand. J. Rheumatol. 26 (1997) 24-29
77. Malik S.W., Myers J.L., DeRemee R.A., and Specks U. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am. J. Respir. Crit. Care Med. 154 (1996) 1851-1856
78. Manchul L.A., Jin A., Pritchard K.I., Tenenbaum J., Boyd N.F., Lee P., Germanson T., and Gordon D.A. The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch. Intern. Med. 145 (1985) 1835-1839
79. Marguerie C., Bunn C.C., Beynon H.L., Bernstein R.M., Hughes J.M., So A.K., and Walport M.J. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q. J. Med. 77 (1990) 1019-1038
80. Marie I., Hatron P.Y., Hachulla E., Wallaert B., Michon-Pasturel U., and Devulder B. Pulmonary involvement in polymyositis and in dermatomyositis. J. Rheumatol. 25 (1998) 1336-1343
81. Marie I., Hachulla E., Hatron P.Y., Hellot M.F., Levesque H., Devulder B., and Courtois H. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J. Rheumatol. 28 (2001) 2230-2237
82. Marie I., Hachulla E., Cherin P., Dominique S., Hatron P.Y., Hellot M.F., Devulder B., Herson S., Levesque H., and Courtois H. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 47 (2002) 614-622
83. Martinez F., Flaherty K., Travis W., and Lynch III J.P. Nonspecific interstitial pneumonia. In: Lynch III J.P. (Ed). Idiopathic Pulmonary Fibrosis (2003), Marcel Dekker, New York 101-136
84. Medsger Jr. T.A., Robinson H., and Masi A.T. Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum. 14 (1971) 249-258
85. Mehregan D.R., and Su W.P. Cyclosporine treatment for dermatomyositis/polymyositis. Cutis 51 (1993) 59-61
86. Mino M., Noma S., Taguchi Y., Tomii K., Kohri Y., and Oida K. Pulmonary involvement in polymyositis and dermatomyositis: sequential evaluation with CT. AJR Am. J. Roentgenol. 169 (1997) 83-87
87. Miyake S., Ohtani Y., Sawada M., Inase N., Miyazaki Y., Takano S., Miyasaka N., and Yoshizawa Y. Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis. Sarcoidosis Vasc. Diffuse Lung Dis. 19 (2002) 128-133
88. Mok C.C., To C.H., and Szeto M.L. Successful treatment of dermatomyositis-related rapidly progressive interstitial pneumonitis with sequential oral cyclophosphamide and azathioprine. Scand. J. Rheumatol. 32 (2003) 181-183
89. Nakajima H., Harigai M., Hara M., Hakoda M., Tokuda H., Sakai F., Kamatani N., and Kashiwazaki S. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J. Rheumatol. 27 (2000) 1164-1170
90. Nambu Y., Mouri M., Toga H., Ohya N., Iwata T., and Kobashi Y. Gender and underlying diseases affect the frequency of the concurrence of adult polymyositis/dermatomyositis and interstitial pneumonia. Chest 106 (1994) 1931-1932
91. Nawata Y., Kurasawa K., Takabayashi K., Miike S., Watanabe N., Hiraguri M., Kita Y., Kawai M., Saito Y., and Iwamoto I. Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J. Rheumatol. 26 (1999) 1527-1533
92. Oddis C.V. Current approach to the treatment of polymyositis and dermatomyositis. Curr. Opin. Rheumatol. 12 (2000) 492-497
93. Oddis C.V., Sciurba F.C., Elmagd K.A., and Starzl T.E. Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353 (1999) 1762-1763
94. Ohnishi H., Yokoyama A., Kondo K., Hamada H., Abe M., Nishimura K., Hiwada K., and Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 165 (2002) 378-381
95. Rowen A.J., and Reichel J. Dermatomyositis with lung involvement, successfully treated with azathioprine. Respiration 44 (1983) 143-146
96. Saito Y., Terada M., Takada T., Ishida T., Moriyama H., Ooi H., Hasegawa T., Tsukada H., Suzuki E., Gejyo F., and Kihara Y. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J. Comput. Assist. Tomogr. 26 (2002) 349-357
97. Salmeron G., Greenberg S.D., and Lidsky M.D. Polymyositis and diffuse interstitial lung disease. A review of the pulmonary histopathologic findings. Arch. Intern. Med. 141 (1981) 1005-1010
98. Sano M., Suzuki M., Sato M., Sakamoto T., and Uchigata M. Fatal respiratory failure due to polymyositis. Intern. Med. 33 (1994) 185-187
99. Sauty A., Rochat T., Schoch O.D., Hamacher J., Kurt A.M., Dayer J.M., and Nicod L.P. Pulmonary fibrosis with predominant CD8 lymphocytic alveolitis and anti-Jo-1 antibodies. Eur. Respir. J. 10 (1997) 2907-2912
100. Schiavi E.A., Roncoroni A.J., and Puy R.J. Isolated bilateral diaphragmatic paresis with interstitial lung disease. An unusual presentation of dermatomyositis. Am. Rev. Respir. Dis. 129 (1984) 337-339
101. Schmidt W.A., Wetzel W., Friedlander R., Lange R., Sorensen H.F., Lichey H.J., Genth E., Mierau R., and Gromnica-Ihle E. Clinical and serological aspects of patients with anti-Jo-1 antibodies-an evolving spectrum of disease manifestations. Clin. Rheumatol. 19 (2000) 371-377
102. Schnabel A., Reuter M., and Gross W.L. Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum. 41 (1998) 1215-1220
103. Schnabel A., Reuter M., Biederer J., Richter C., and Gross W.L. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin. Arthritis Rheum. 32 (2003) 273-284
104. Schumacher H.R., Schimmer B., Gordon G.V., Bookspan M.A., Brogadir S., and Dorwart B.B. Articular manifestations of polymyositis and dermatomyositis. Am. J. Med. 67 (1979) 287-292
105. Schurawitzki H., Stiglbauer R., Graninger W., Herold C., Polzleitner D., Burghuber O.C., and Tscholakoff D. Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography. Radiology 176 (1990) 755-759
106. Schwarz M.I. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J. Thorac. Imaging 7 (1992) 46-54
107. Schwarz M.I. The lung in polymyositis. Clin. Chest Med. 19 (1998) 701-712 viii
108. Schwarz M.I., Matthay R.A., Sahn S.A., Stanford R.E., Marmorstein B.L., and Scheinhorn D.J. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 55 (1976) 89-104
109. Schwarz M.I., Sutarik J.M., Nick J.A., Leff J.A., Emlen J.W., and Tuder R.M. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am. J. Respir. Crit. Care Med. 151 (1995) 2037-2040
110. Sharp G.C., Irvin W.S., Tan E.M., Gould R.G., and Holman H.R. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52 (1972) 148-159
111. Shinohara T., Hidaka T., Matsuki Y., Ishizuka T., Takamizawa M., Kawakami M., Kikuma H., Suzuki K., and Nakamura H. Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern. Med. 36 (1997) 519-523
112. Sigurgeirsson B., Lindelof B., Edhag O., and Allander E. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N. Engl. J. Med. 326 (1992) 363-367
113. Silver R.M., Miller K.S., Kinsella M.B., Smith E.A., and Schabel S.I. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am. J. Med. 88 (1990) 470-476
114. Songcharoen S., Raju S.F., and Pennebaker J.B. Interstitial lung disease in polymyositis and dermatomyositis. J. Rheumatol. 7 (1980) 353-360
115. Sontheimer R.D., and Miyagawa S. Potentially fatal interstitial lung disease can occur in clinically amyopathic dermatomyositis. J. Am. Acad. Dermatol. 48 (2003) 797-798
116. Stedeford J., and Wordsworth B.P. Cyclosporin A treatment of dermatomyositis. Arthritis Rheum. 34 (1991) 933
117. Sugisaki K., Takeda I., Iwadate H., Kanno T., Nishimaki T., and Kasukawa R. Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine/cyclophosphamide in two patients with amyopathic dermatomyositis. Fukushima J. Med. Sci. 48 (2002) 103-110
118. Sullivan W.D., Hurst D.J., Harmon C.E., Esther J.H., Agia G.A., Maltby J.D., Lillard S.B., Held C.N., Wolfe J.F., Sunderrajan E.V., Maricq H.R., and Sharp G.R. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 63 (1984) 92-107
119. Takahashi H., Fujishima T., Koba H., Murakami S., Kurokawa K., Shibuya Y., Shiratori M., Kuroki Y., and Abe S. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 162 (2000) 1109-1114
120. Takahashi H., Kuroki Y., Tanaka H., Saito T., Kurokawa K., Chiba H., Sagawa A., Nagae H., and Abe S. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am. J. Respir. Crit. Care Med. 162 (2000) 258-263
121. Takizawa H., Shiga J., Moroi Y., Miyachi S., Nishiwaki M., and Miyamoto T. Interstitial lung disease in dermatomyositis: clinicopathological study. J. Rheumatol. 14 (1987) 102-107
122. Takizawa H., Suzuki N., Yanagawa T., Okazaki H., Satoh M., Akiyama N., Kohyama T., Kawasaki S., Ito K., and Oka T. Outcome in patients with interstitial lung disease and polymyositis-dermatomyositis-a subgroup with poor prognosis. Nihon Kyobu Shikkan Gakkai Zasshi 34 (1996) 1093-1097
123. Tanaka F., Origuchi T., Migita K., Tominaga M., Kawakami A., Kawabe Y., and Eguchi K. Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis. Intern. Med. 39 (2000) 428-430
124. Targoff I.N. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J. Immunol. 144 (1990) 1737-1743
125. Targoff I.N. Immune manifestations of inflammatory muscle disease. Rheum. Dis. Clin. North Am. 20 (1994) 857-880
126. Targoff I.N., Arnett F.C., Berman L., O'Brien C., and Reichlin M. Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. J. Clin. Invest. 84 (1989) 162-172
127. Tazelaar H.D., Viggiano R.W., Pickersgill J., and Colby T.V. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am. Rev. Respir. Dis. 141 (1990) 727-733
128. Turner R., Lipshutz W., Miller W., Rittenberg G., Schumacher H.R., and Cohen S. Esophageal dysfunction in collagen disease. Am. J. Med. Sci. 265 (1973) 191-199
129. Vazquez-Abad D., and Rothfield N.F. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Arthritis Rheum. 39 (1996) 292-296
130. Wallaert B., Hatron P.Y., Grosbois J.M., Tonnel A.B., Devulder B., and Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. Am. Rev. Respir. Dis. 133 (1986) 574-580
131. Wells A.U., du Bois R.M., and Nicholson A. Pulmonary fibrosis in connective tissue disease. In: Lynch III J.P. (Ed). Idiopathic Pulmonary Fibrosis (2003), Marcel Dekker, New York 273-302
132. White B., Moore W.C., Wigley F.M., Xiao H.Q., and Wise R.A. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann. Intern. Med. 132 (2000) 947-954
133. Yamadori I., Fujita J., Kajitani H., Bandoh S., Tokuda M., Ohtsuki Y., Yoshinouchi T., Okahara M., Yamaji Y., Tanimoto Y., Sato Y., and Ishida T. Lymphocyte subsets in lung tissues of interstitial pneumonia associated with untreated polymyositis/dermatomyositis. Rheumatol. Int. 21 (2001) 89-93
134. Yamanishi Y., Maeda H., Konishi F., Hiyama K., Yamana S., Ishioka S., and Yamakido M. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand. J. Rheumatol. 28 (1999) 58-61
135. Yang Y., Fujita J., Tokuda M., Bandoh S., and Ishida T. Chronological evaluation of the onset of histologically confirmed interstitial pneumonia associated with polymyositis/dermatomyositis. Intern. Med. 41 (2002) 1135-1141
136. Yoshida S., Akizuki M., Mimori T., Yamagata H., Inada S., and Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 26 (1983) 604-611
137. Yoshida T., Koga H., Saitoh F., Sakamoto M., Harada M., Yoshida H., Sakisaka S., and Sata M. Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Intern. Med. 38 (1999) 733-738
138. Zisman D.A., McCune W.J., Tino G., and Lynch III J.P. Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc. Diffuse Lung Dis. 18 (2001) 243-252